info@biomedres.us   +1 (720) 414-3554   600 Third Avenue, 2nd floor, New York - 10016, USA
ISSN: 2574 -1241

Case ReportOpen Access

Sapien XT Implantation in Mitral Position

Volume 2 - Issue 3

Stefano Salizzoni1, Giovanni Marchetto1, Matteo Marro*1, Andrea Baronetto1, Marcella Jorfida2, Maurizio D Amico2, and Mauro Rinaldi1

  • Author Information Open or Close
    • 1Department of Surgical Sciences, Division of Cardiac Surgery, Italy
    • 2Department of Medical Sciences, Division of Cardiology, Italy

    *Corresponding author: Matteo Marro, Corso Bramante 88, 10126 Torino, Italy, Tel: +39-011-6335511; Email: matteo.marro1@gmail.com

Received: February 02, 2018;   Published: February 09, 2018

DOI: 10.26717/BJSTR.2018.02.000750

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Degeneration of bioprosthesis may occur in elderly and frail patients with an extremely high risk for redo cardiac surgery. Transcatheter valve-in-valve procedures represent a valuable treatment option in high-risk patients [1,2]. However incidental findings may contraindicate the transcatheter procedure. We describe the original case of a patient who was scheduled for transapical mitral valve-in-valve, but due to a left a trial mass underwent mini-invasive surgery with successful direct mitral valve-in-valve delivery and excision of the mass.

Keywords: TAVI; Transcatheter; Mitral; Valve-in-valve; Bioprosthesis failure; Minimally invasive surgery

Abstract| Introduction| Conclusions| References|